In conclusion, our results demonstrated that maternal HFrD intake during gestation can cause activation of the ChREBP-progesterone-ChREBP loop in female offspring, thereby promoting IR and hepatic steatosis. The gene discussed is MLXIPL; the disease is fatty liver disease.